Disorders of sex development 46 XY and bilateral metachronous wilms tumor in a child with mutation in exon 7 of WT1 gene


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Denys-Drash syndrome is characterized by a triad: nephropathy, a 46, XY disorder of sex development, and nephroblastoma with mutations in the gene WT1. A clinical case of a patient with a bilateral metachronous Wilms' tumor, a 46, XY disorder of sex development in the form of a scrotal hypospadias and bilateral abdominal cryptorchidism, without nephropathy with a mutation in 7 exon of gene WT1 is presented in the article. The child underwent left-sided nephrectomy, lower pole right partial nephrectomy, bilateral orchiopexy and two-stage correction of hypospadias. After 7 years from the start of treatment and 3 years after the last procedure, the child’s condition has been assessed as satisfactory. The presented case, according to the analysis of literature, has not been previously described, therefore, it currently remains as “de novo” and requires further observation.

Full Text

Restricted Access

About the authors

N. R Akramov

Kazan State Medical University; Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan

Email: aknail@rambler.ru
MD, Professor, Chief Researcher of the Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Professor of the Department of Pediatric Surgery Kazan, Russia

I. V Osipova

Children's Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan

Email: ivos29@mail.ru
Head of the Department of Oncohematology Kazan, Russia

A. K Zakirov

Kazan State Medical University; Children's Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan

Email: dwc@yandex.ru
Ph.D., assistant at the Department of Pediatric Surgery Kazan, Russia

E. I Khaertdinov

Kazan State Medical University

Email: khelmir@yandex.ru
Ph.D. student at the Department of Pediatric Surgery Kazan, Russia

References

  1. National Wilms’ Tumor Study Committee. Wilms’ tumor: status report, 1990. J. Clin. Oncol. 1991;9,877-887. doi: 10.1200/JCO.1991.9.5.877.
  2. Stefan D.C. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61(3):165-173. doi: 10.1093/tropej/fmv005.
  3. Kulyova S.A., Imyanitov E.N. Wilm’s Tumor: Syndrome-based and Molecular Diagnostics. Onkopediatria. 2017;4(4):283-289. Russian (Кулева С.А., Имянинов Е.Н. Опухоль Вильмса: синдром альная и молекулярная диагностика. Онкопедиатрия. 2017;4(4):283-289). doi: 10.15690/onco.v4i4.1814.
  4. Ward E., DeSantis C., Robbins A., et al. Childhood and Adolescent Cancer Statistics. Cancer J Clin. 2014;64:83-103. doi: 10.3322/caac.21219.
  5. Green D.M. The treatment of stages I-IV favorable histology Wilms’ tumor. J ClinOncol 2004;22(8):1366-1372. doi: 10.1200/JC0.2004.08.008.
  6. Weirich A., Ludwig R., Graf N., et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol 2004;15:808-820. doi: 10.1093/annonc/mdh171.
  7. Denys P., Malvaux P., van den Berghe H., et al. Association d’un syndrome anatomo-pathologique de pseudohermaphrodismemasculin, d’unetumeur de Wilms, d’unenephropathieparenchymateuse et d’un mosaicisme XX/ XY. Arch. Franc. Pediat. 1967;24:729-739.
  8. Drash A., Sherman F., Hartmann W.H., Blizzard R.M. A syndrome of pseudohermaphroditism, Wilms’ tumor, hypertension, and degenerative renal disease. J. Pediat. 1970;76:585-593. doi: 10.1016/s0022-3476(70)80409-7.
  9. Bruening W., Bardeesy N., Silverman B.L., et al. Germlineintronic and exonic mutations in the Wilms’ tumour gene (WT1) affecting urogenital development. Nat Genet. 1992;1(2):144-148. doi: 10.1038/ng0592-144.
  10. Auber F., Lortat-Jacob S., Sarnacki S., et al. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes). J Pediatr Surg. 2003;38( 1): 124-129. Doi: 10.1053/ jpsu.2003.50025.
  11. Takata A., Kikuchi H., Fukuzawa R., et al. Constitutional WT1 correlate with clinical features in children with progressive nephropathy. J Med Genet. 2000;37(9):698-701. doi: 10.1136/jmg.37.9.698.
  12. da Silva T.E., Nishi M.Y., Costa E.M., et al. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome. PediatrNephrol. 2011;26(8):1311-1315. doi: 10.1007/s00467-011-1847-4.
  13. Fukuzawa R., Sakamoto J., Heathcott R.W., Hata J.I. A necropsy case of Denys-Drash syndrome with a WT1 mutation in exon 7. J Med Genet. 2002;39(8):e48. doi: 10.1136/jmg.39.8.e48.
  14. Jeanpierre C., Beroud C., Niaudet P., Junien C. Software and database for the analysis of mutations in the human WT1 gene. Nucleic Acids Res. 1998;26(1):271-274. doi: 10.1093/nar/26.1.271.
  15. Little M., Wells C. A clinical overview ofWT1 gene mutations. Hum Mutat. 1997;9(3):209-225. doi: 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2
  16. Bardeesy N., Zabel B., Schmitt K., Pelletier J. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics. 1994;21(3):663-664. doi: 10.1006/geno.1994.1333.
  17. Weaver J., Rove K.O., Meenakshi-Sundaram B., Vricella G.J. Genetic testing proves crucial in case of ambiguousgenitalia and renal masses. Urology. 2019;125:194-196. doi: 10.1016/j.urology.2019.03.011.
  18. Chiang P.W., Aliaga S., Travers S., et al. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome. CurrOpinPediatr. 2008;20(1):103-106. Doi: 10.1097/ MOP/0b013e3282f357eb.
  19. Lehnhardt A., Karnatz C., Ahlenstiel-Grunow T. et al. Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1. Clin J Am SocNephrol. 2015; 10(5):825-831. doi: 10.2215/CJN.10141014.
  20. Dattolo P., Allinovi M., Iatropoulos P., Michelassi S. Atypical clinical presentation of a WT1-related syndrome associated with a novel exon 6 gene mutation. BMJ Case Rep. 2013;27;2013. doi: 10.1136/bcr-2013-009543.
  21. Kohler B., Biebermann H., Friedsam V., et al. Analysis ofthe Wilms’ tumor suppressor gene (WT1) in patients 46,XY disorders of sex development. J ClinEndocrinol Metab 2011 ;96:E113-E1136. doi: 10.1210/jc.2010-2804.
  22. Finken M.J., Hendriks Y.M., van der Voorn J.P., et al. WT1 deletion leading to severe 46,XY gonadal dysgenesis, Wilms tumor and gonadoblastoma: case report. Horm Res Paediatr. 2015;83(3):211-216. doi: 10.1159/000368964.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies